I agree that this site is using cookies. You can find further informations here.
X
Futami, Yu
30  results:
Search for persons X
?
1

SFTPB in serum extracellular vesicles as a biomarker of pro..:

Enomoto, Takatoshi ; Shirai, Yuya ; Takeda, Yoshito...
JCI Insight.  9 (2024)  11 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
2

Sema6D forward signaling impairs T cell activation and prol..:

Hirai, Takashi ; Naito, Yujiro ; Koyama, Shohei...
JCI Insight.  9 (2024)  3 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
3

Identification of CD14 and lipopolysaccharide-binding prote..:

Futami, Yu ; Takeda, Yoshito ; Koba, Taro...
International Immunology.  34 (2022)  6 - p. 327-340 , 2022
Link: https://doi.org/10.1093/..
 
?
4

Proteomics of serum extracellular vesicles identifies a nov..:

Koba, Taro ; Takeda, Yoshito ; Narumi, Ryohei...
ERJ Open Research.  7 (2021)  1 - p. 00658-2020 , 2021
Link: https://doi.org/10.1183/..
 
?
5

Pathological and therapeutic implications of eosinophil-der..:

Tsuda, Takeshi ; Nishide, Masayuki ; Maeda, Yohei...
Journal of Allergy and Clinical Immunology.  145 (2020)  3 - p. 843-854.e4 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Identification of CD14 and lipopolysaccharide-binding prote..:

Futami, Yu ; Takeda, Yoshito ; Koba, Taro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166566/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Clinical implications of monitoring nivolumab immunokinetic..:

Osa, Akio ; Uenami, Takeshi ; Koyama, Shohei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237460/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

Carboplatin plus weekly nanoparticle albumin-bound paclitax..:

Shiroyama, Takayuki ; Tamiya, Motohiro ; Minami, Seigo...
Cancer Chemotherapy and Pharmacology.  80 (2017)  3 - p. 461-467 , 2017
Link: https://doi.org/10.1007/..
 
?
9

Phase II trial of induction chemotherapy of pemetrexed plus..:

Koba, Taro ; Minami, Seigo ; Nishijima-Futami, Yu...
Cancer Chemotherapy and Pharmacology.  82 (2018)  1 - p. 111-117 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Phase II study of S-1 plus bevacizumab combination therapy ..:

Nishijima-Futami, Yu ; Minami, Seigo ; Futami, Shinji...
Cancer Chemotherapy and Pharmacology.  79 (2017)  6 - p. 1215-1220 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Proteomics of serum extracellular vesicles identifies a nov..:

Taro Koba ; Yoshito Takeda ; Ryohei Narumi...
http://openres.ersjournals.com/content/7/1/00658-2020.full.  , 2021
Link: https://doi.org/10.1183/..
 
?
12

Histological differentiation between sporadic and colitis‐a..:

Uchino, Motoi ; Ikeuchi, Hiroki ; Noguchi, Tatsuki...
Journal of Gastroenterology and Hepatology.  39 (2024)  5 - p. 893-901 , 2024
Link: https://doi.org/10.1111/..
 
?
13

Prognostic impact of tumour location in stage II/III ulcera..:

Mizuuchi, Yusuke ; Nagayoshi, Kinuko ; Nakamura, Masafumi...
British Journal of Surgery.  111 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

Hydroxyapatite in Whitlockite-Based Hypermineralized Hard T..:

Iijima, Mayumi ; Komatsu, Kazuki ; Kagi, Hiroyuki...
Crystal Growth & Design.  23 (2023)  4 - p. 2031-2041 , 2023
Link: https://doi.org/10.1021/..
 
?
15

Crohn's Disease–Associated Anorectal Cancer Has a Poor Prog..:

Ogino, Takayuki ; Mizushima, Tsunekazu ; Fujii, Makoto...
American Journal of Gastroenterology.  118 (2023)  9 - p. 1626-1637 , 2023
Link: https://doi.org/10.14309..
 
1-15